These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21487418)

  • 61. Impact of tamoxifen adjuvant therapy on symptoms, functioning, and quality of life.
    Ganz PA
    J Natl Cancer Inst Monogr; 2001; (30):130-4. PubMed ID: 11773306
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Knowledge of Potential Harms and Benefits of Tamoxifen among Women Considering Breast Cancer Preventive Therapy.
    Thorneloe RJ; Hall LH; Walter FM; Side L; Lloyd KE; Smith SG;
    Cancer Prev Res (Phila); 2020 Apr; 13(4):411-422. PubMed ID: 31988145
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Tamoxifen in the prevention of breast cancer. Are the risks likely to outweigh the benefits?
    O'Brien M; Powles TJ
    Drug Saf; 1994 Jan; 10(1):1-4. PubMed ID: 8136084
    [No Abstract]   [Full Text] [Related]  

  • 64. Long-term benefits of 5 years of tamoxifen: 10-year follow-up of a large randomized trial in women at least 50 years of age with early breast cancer.
    Hackshaw A; Roughton M; Forsyth S; Monson K; Reczko K; Sainsbury R; Baum M
    J Clin Oncol; 2011 May; 29(13):1657-63. PubMed ID: 21422412
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Tamoxifen and breast cancer--from palliation to prevention.
    Rich SE
    Cancer Nurs; 1993 Oct; 16(5):341-6. PubMed ID: 7505194
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Gynecologic complications associated with long-term adjuvant tamoxifen therapy for breast cancer.
    Wolf DM; Jordan VC
    Gynecol Oncol; 1992 May; 45(2):118-28. PubMed ID: 1592278
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hormonal Therapy and Chemoprevention.
    Bonanni B; Guerrieri-Gonzaga A; Rotmensz N; Torrisi R; Pigatto F; Cazzaniga M; Mora S; Diani S; Robertson C; Decensi A
    Breast J; 2000 Oct; 6(5):317-323. PubMed ID: 11348390
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Chemoprevention of breast cancer in the older patient.
    Minton SE
    Hematol Oncol Clin North Am; 2000 Feb; 14(1):113-30. PubMed ID: 10680075
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prevention of breast cancer.
    Jones AL; Powles TJ
    Curr Opin Oncol; 1991 Dec; 3(6):1024-8. PubMed ID: 1843103
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Long-term adjuvant tamoxifen therapy for breast cancer: the prelude to prevention.
    Jordan VC
    Cancer Treat Rev; 1990 Mar; 17(1):15-36. PubMed ID: 2224868
    [No Abstract]   [Full Text] [Related]  

  • 71. Preliminary assessment of cognitive function in breast cancer patients treated with tamoxifen.
    Paganini-Hill A; Clark LJ
    Breast Cancer Res Treat; 2000 Nov; 64(2):165-76. PubMed ID: 11194452
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Long-term adjuvant tamoxifen therapy for breast cancer.
    Jordan VC
    Breast Cancer Res Treat; 1990 May; 15(3):125-36. PubMed ID: 2196941
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Risks, benefits, and effects on quality of life of selective estrogen-receptor modulator therapy in postmenopausal women at increased risk of breast cancer.
    Ganz PA; Land SR
    Menopause; 2008; 15(4 Suppl):797-803. PubMed ID: 18596601
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pharmacogenetics and breast cancer endocrine therapy: CYP2D6 as a predictive factor for tamoxifen metabolism and drug response?
    Stearns V; Rae JM
    Expert Rev Mol Med; 2008 Nov; 10():e34. PubMed ID: 19019258
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Molecular mechanisms of tamoxifen-associated endometrial cancer (Review).
    Hu R; Hilakivi-Clarke L; Clarke R
    Oncol Lett; 2015 Apr; 9(4):1495-1501. PubMed ID: 25788989
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Upregulation of ventricular potassium channels by chronic tamoxifen treatment.
    El Gebeily G; Fiset C
    Cardiovasc Res; 2011 Apr; 90(1):68-76. PubMed ID: 21131637
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effects of short- and long-term administration of tamoxifen on hCG-induced testicular steroidogenesis in man: no evidence for an oestradiol-induced steroidogenic lesion.
    van Bergeijk L; Gooren LJ; van der Veen EA; de Vries CP
    Int J Androl; 1985 Feb; 8(1):28-36. PubMed ID: 3997269
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Long-term follow-up in cancer prevention trials (It ain't over 'til it's over).
    Cuzick J
    Cancer Prev Res (Phila); 2010 Jun; 3(6):689-91. PubMed ID: 20522799
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Low-dose tamoxifen treatment in juvenile males has long-term adverse effects on the reproductive system: implications for inducible transgenics.
    Patel SH; O'Hara L; Atanassova N; Smith SE; Curley MK; Rebourcet D; Darbey AL; Gannon AL; Sharpe RM; Smith LB
    Sci Rep; 2017 Aug; 7(1):8991. PubMed ID: 28827578
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The role of selective estrogen receptor modulators on breast cancer: from tamoxifen to raloxifene.
    Lee WL; Cheng MH; Chao HT; Wang PH
    Taiwan J Obstet Gynecol; 2008 Mar; 47(1):24-31. PubMed ID: 18400579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.